Lidocaine HCI 2% and Epinephrine 1:100
Recalled by Novocol Pharmaceutical of Canada, Inc.
Class II — moderate
Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Novocol Pharmaceutical of Canada, Inc. has recalled Lidocaine HCI 2% and Epinephrine 1:100, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on December 24, 2025 and was initiated on October 31, 2025. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers Lidocaine HCI 2% and Epinephrine 1:100, with approximately 12,033 cartons affected. The company behind the recall is Novocol Pharmaceutical of Canada, Inc., based in Cambridge. The FDA describes the product as: “Lidocaine HCI 2% and Epinephrine 1:100,000 (Lidocaine HCI and Epinephrine Injection USP), packaged in a carton containing 50 single-dose Cartridges, 1.7 ml each, Rx only, Manufactured for Patterson Dental Supply, Inc., 1031 Mendota Heights Road, Saint Paul, M…”
Why was Lidocaine HCI 2% and Epinephrine 1:100 recalled?
According to the FDA, the stated reason for the recall is: “Defective container: cracked/broken cartridges.”
What should you do?
If you think you may have bought Lidocaine HCI 2% and Epinephrine 1:100, compare it against the product description and identifying codes (Lot: D05362A, expires: 07-31-2027) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Novocol Pharmaceutical of Canada, Inc. or your local health authority.
About this recall
This recall was distributed in U.S.A. Nationwide. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Who this recall affects
This recall matters to anyone who bought Lidocaine HCI 2% and Epinephrine 1:100. Even if you feel fine, it's worth checking what you have on hand rather than assuming you were missed.
Distribution listed in the notice: U.S.A. Nationwide.
How to check whether you have it
On medicine bottles, the lot number and expiration date are printed on the pharmacy label or stamped directly on the manufacturer's bottle — often near the bottom edge or on the back. If a pharmacy label covers it, your pharmacist can look up the lot they dispensed.
Compare what you find against the identifying details in this recall: Lot: D05362A, expires: 07-31-2027
What to do if you already bought it
Do not stop taking a prescribed medicine on your own because of a recall — for many conditions, an interrupted dose carries its own risk.
Instead, check the lot number against the details above and contact your pharmacist, who can confirm what they dispensed and arrange a replacement.
If you've had an unexpected reaction, contact your healthcare provider. Problems can also be reported to the FDA's MedWatch program.
Full recall details
- Status
- Ongoing
- Date reported
- December 24, 2025
- Recall started
- October 31, 2025
- Distributed in
- U.S.A. Nationwide
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was Lidocaine HCI 2% and Epinephrine 1:100 recalled?+
According to the FDA: Defective container: cracked/broken cartridges
How serious is this recall?+
Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
What should I do if I have Lidocaine HCI 2% and Epinephrine 1:100?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0229-2026. Information last synced from the FDA on August 3, 2026.